enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. FDA Issues Urgent Warning on Dangers of Common Dog Medication

   www.aol.com/lifestyle/fda-issues-urgent-warning...

   The United States Food and Drugs Administration is warning pet owners about a common medication given to pets to treat arthritis. The F.D.A. now says that the drug Librela may be associated with ...

3. Fluoxetine - Wikipedia

   en.wikipedia.org/wiki/Fluoxetine

   Fluoxetine, sold under the brand name Prozac, among others, is an antidepressant of the selective serotonin reuptake inhibitor (SSRI) class. [2] It is used for the treatment of major depressive disorder, obsessive–compulsive disorder (OCD), anxiety, bulimia nervosa, panic disorder, and premenstrual dysphoric disorder. [2]

4. Your Guide to the 6 Most Common Types of Depression Medications

   www.aol.com/6-types-depression-medications...

   Fluoxetine has common side effects, like many antidepressants, and some people who take this drug have trouble concentrating. ... but it can be increased to a maximum safe dose of 225 milligrams ...

5. Tricyclic antidepressant - Wikipedia

   en.wikipedia.org/wiki/Tricyclic_antidepressant

   Side effects may also be less troublesome if treatment is initiated with low doses and then gradually increased, although this may also delay the beneficial effects. TCAs can behave like class 1A antiarrhythmics , as such, they can theoretically terminate ventricular fibrillation, decrease cardiac contractility and increase collateral blood ...

6. Switching Antidepressants: Safety, Side Effects & Other ... - AOL

   www.aol.com/switching-antidepressants-safety...

   Despite their side effects, some tricyclic antidepressants may be effective for improving depression symptoms when other, newer medications aren’t effective. Atypical antidepressants.

7. Selective serotonin reuptake inhibitor - Wikipedia

   en.wikipedia.org/wiki/Selective_serotonin...

   A 2012 meta-analysis of fluoxetine and venlafaxine concluded that statistically and clinically significant treatment effects were observed for each drug relative to placebo irrespective of baseline depression severity; some of the authors however disclosed substantial relationships with pharmaceutical industries. [14]